Field Activation Specialist - Long Beach
Gilead Sciences- Full Time
- Junior (1 to 2 years)
Employment Type: Full-Time
Location: Santa Monica, CA (Field-based; must reside in territory)
GRAIL is seeking an Associate GRAIL Galleri Consultant (aGGC) to join our sales team. This field-based role is responsible for service and sales support activities to drive market adoption and business growth for GRAIL's innovative cancer detection technologies. The aGGC will support GRAIL Galleri Consultants (GGC) in increasing revenue and developing the market through direct sales to individual physicians. Key support efforts include cultivating and maintaining relationships, creating and executing strategic business plans, and focusing on currently marketed products and new product launches.
Our mission is to detect cancer early, when it can be cured. We are working to change the trajectory of cancer mortality and bring stakeholders together to adopt innovative, safe, and effective technologies that can transform cancer care. We are a healthcare company, pioneering new technologies to advance early cancer detection. We have built a multi-disciplinary organization of scientists, engineers, and physicians and we are using the power of next-generation sequencing (NGS), population-scale clinical studies, and state-of-the-art computer science and data science to overcome one of medicine’s greatest challenges.
GRAIL is headquartered in Menlo Park, California, with locations in Washington, D.C., North Carolina, and the United Kingdom. It is supported by leading global investors and pharmaceutical, technology, and healthcare companies. For more information, please visit grail.com.
Develops blood tests for early cancer detection
GRAIL focuses on improving cancer detection through advanced blood tests that identify cancer at its earliest stages, enhancing treatment success rates. The company utilizes high-intensity sequencing to analyze tumor genome data, employing algorithms and deep learning to extract actionable information for early cancer detection. GRAIL differentiates itself from competitors by its commitment to large-scale clinical studies that validate the effectiveness of its tests. The primary goal is to reduce global cancer mortality by enabling early diagnosis, making the disease more treatable.